Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Invivyd, Inc.

NASDAQ: IVVD · Life Sciences · 3 alerts · CIK 1832038

Share price
$0.5377Close, Nov 16
Market cap
$159M
Shares outstanding
295.63MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Invivyd, Inc. filings on SEC EDGAR ↗

7:27 AM ET 8-K
Clinical Trial Data

Invivyd Clinical Trial Data

Invivyd announced positive topline results from its LIBERTY Phase 3 study, which demonstrated that its COVID-19 monoclonal antibody candidate, VYD2311, had safety and tolerability superior to an mRNA-based vaccine. The company plans to use data from LIBERTY and the ongoing DECLARATION pivotal study to support a Biologics License Application (BLA) submission to the FDA via the Accelerated Approval Program.

Earnings call
Sep 29, 2026, 8:30 AM ET

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.